U.S. Markets closed
LISTEN

Schultz: Businesses need to do more to help people

Yahoo Finance's Julia La Roche sits down with executive chairman and former CEO of Starbucks Howard Schultz

Puma Biotechnology, Inc. (PBYI)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
104.50-0.30 (-0.29%)
At close: 4:00PM EDT

104.50 0.00 (0.00%)
After hours: 4:42PM EDT

People also watch
CLVSICPTKITETSROBLUE
Full screen
Previous Close104.80
Open104.40
Bid90.00 x 100
Ask108.50 x 500
Day's Range102.65 - 104.85
52 Week Range28.35 - 109.85
Volume359,028
Avg. Volume910,032
Market Cap3.89B
Beta2.13
PE Ratio (TTM)-12.84
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Before You Buy Puma Biotechnology Inc’s (PBYI), You Should Consider This
    Simply Wall St.9 days ago

    Before You Buy Puma Biotechnology Inc’s (PBYI), You Should Consider This

    If you are looking to invest in Puma Biotechnology Inc’s (NASDAQ:PBYI), or currently own the stock, then you need to understand its beta in order to understand how it canRead More...

  • 4 Biotech Stocks for the Long-Term
    InvestorPlace10 days ago

    4 Biotech Stocks for the Long-Term

    Biotech stocks have been a favorite of fast money, too, since it moves faster than the Standard & Poor’s 500 – in both directions. Some stocks, such as Vertex Pharmaceuticals (NASDAQ:VRTX), are already up triple-digit percentages this year. Or, they may be emerging from long trading ranges where uncertainty previously ruled.

  • Puma (PBYI) Q2 Loss Narrower than Expected, Nerlynx in Focus
    Zackslast month

    Puma (PBYI) Q2 Loss Narrower than Expected, Nerlynx in Focus

    Puma Biotechnology (PBYI) reported narrower-than-expected loss in Q2. Shares were down in after-hours trading.